GSK-2894631A is primarily utilized in research settings to study its potential therapeutic effects, particularly in the field of oncology. It is investigated for its role in inhibiting specific signaling pathways that are implicated in cancer cell proliferation and survival. Researchers are exploring its efficacy in preclinical models to determine its potential as a targeted therapy for various types of cancers. Additionally, it is used to understand the molecular mechanisms underlying tumor growth and resistance to conventional treatments. The compound’s ability to modulate key cellular processes makes it a valuable tool in the development of novel anticancer strategies.